Alera Investment Advisors’s iBio IBIO Stock Holding History

Alera Investment Advisors’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1	Closed	–	–	493
2019 Q1	$0	Hold	1	–	–	﹤0.01%	1253
2018 Q4	$0	Buy	+1	New	+$387	﹤0.01%	1150

Other funds holding IBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Alera Investment Advisors's IBIO Position: Q2 2019 in Review

Alera Investment Advisors sold out of iBio (IBIO) in Q2 2019, closing a stake of 1 share.

Alera Investment Advisors first reported a position in IBIO in Q4 2018 and held it in 2 quarters. The position peaked at $0 in Q1 2019. 13 funds tracked by Wall St. Rank hold IBIO as of Q2 2019.

Alera Investment Advisors reported no remaining iBio position as of Q2 2019 after selling out during the quarter.
Alera Investment Advisors sold 1 iBio share in Q2 2019.
Alera Investment Advisors first reported a position in iBio in Q4 2018 and held it in 2 quarters.
Alera Investment Advisors's iBio position peaked at $0 in Q1 2019.
13 funds tracked by Wall St. Rank held iBio as of Q2 2019.

Based on Alera Investment Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.